ATE380023T1 - Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung - Google Patents

Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung

Info

Publication number
ATE380023T1
ATE380023T1 AT01116533T AT01116533T ATE380023T1 AT E380023 T1 ATE380023 T1 AT E380023T1 AT 01116533 T AT01116533 T AT 01116533T AT 01116533 T AT01116533 T AT 01116533T AT E380023 T1 ATE380023 T1 AT E380023T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
dependent
solid pharmaceutical
oral solid
release
Prior art date
Application number
AT01116533T
Other languages
English (en)
Inventor
Roberto Valducci
Original Assignee
Roberto Valducci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Valducci filed Critical Roberto Valducci
Application granted granted Critical
Publication of ATE380023T1 publication Critical patent/ATE380023T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01116533T 2000-07-14 2001-07-09 Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung ATE380023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001603A IT1318625B1 (it) 2000-07-14 2000-07-14 Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.

Publications (1)

Publication Number Publication Date
ATE380023T1 true ATE380023T1 (de) 2007-12-15

Family

ID=11445483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01116533T ATE380023T1 (de) 2000-07-14 2001-07-09 Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung

Country Status (8)

Country Link
US (1) US7022345B2 (de)
EP (1) EP1172100B1 (de)
JP (1) JP2002080398A (de)
AT (1) ATE380023T1 (de)
AU (1) AU776099B2 (de)
CA (1) CA2352496A1 (de)
DE (1) DE60131703T2 (de)
IT (1) IT1318625B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
JP4726414B2 (ja) * 2001-10-15 2011-07-20 フェリング ベスローテン フェンノートシャップ 潰瘍性大腸炎およびクローン病の治療に使用するための５−アミノサリチル酸を含む医薬組成物の調製方法
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
WO2003084517A2 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
EP1552833B1 (de) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Herstellung eines amorphen, optisch aktiven Isomers von Lansoprazol
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (de) * 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
AU2008230364A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
MY153062A (en) 2007-10-12 2014-12-31 Takeda Pharmaceuticals Usa Inc Methods of treating gastrointestinal disorders independent of the intake of food
EP2255794A1 (de) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Magensaftresistenter Überzug
HU228001B1 (en) 2010-07-27 2012-08-28 Peter Soldos Equipment for improving physical strength
HU230560B1 (hu) 2010-07-30 2016-12-28 Péter Hajnal pH-függő szakaszos és nyújtott hatóanyagleadású gyógyszerkészítmény
EP2425826A1 (de) * 2010-09-01 2012-03-07 Disphar International B.V. Mesalazin-Tablette mit verbesserter Auflösung
EP2468264A1 (de) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Orale pharmazeutische Tablette zur gesteuerten Abgabe von Mesalazin und Verfahren zu deren Erhalt
CN102784154B (zh) * 2012-09-01 2013-10-09 朱文军 一种美沙拉嗪肠溶片及其制备方法
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
WO2014152450A1 (en) * 2013-03-15 2014-09-25 Warner Chilcott Company, Llc Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
EP3193845A1 (de) 2014-09-19 2017-07-26 The Procter and Gamble Company Darreichungsformen von phenylephrin mit gepulster freisetzung
EP3197436B1 (de) * 2014-09-24 2022-03-09 Vital Beverages Global Inc. Zusammensetzungen und verfahren zur selektiven freisetzung im magendarmtrakt
EP3445340A1 (de) 2016-04-19 2019-02-27 Ferring B.V. Orale pharmazeutische zusammensetzungen von mesalazin
EP3445360B1 (de) 2016-04-19 2020-11-11 CONARIS research institute AG Orale pharmazeutische zusammensetzungen mit nicotinamid
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
TR201722852A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4743248A (en) 1986-08-11 1988-05-10 Alza Corporation Dosage form for delivering acid sensitive beneficial agent
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
DE69014513T2 (de) 1989-09-21 1995-05-24 American Cyanamid Co System des Typs "einmal täglich" zur gepulsten Minocyclinabgabe.
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
WO1992004472A1 (en) * 1990-09-07 1992-03-19 Oklahoma Medical Research Foundation Antigens associated with polymyositis and with dermatomyositis
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
GB2292079B (en) 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
AU694655B2 (en) * 1995-05-02 1998-07-23 Taisho Pharmaceutical Co., Ltd. Composition for oral administration
US5846983A (en) 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent

Also Published As

Publication number Publication date
EP1172100B1 (de) 2007-12-05
IT1318625B1 (it) 2003-08-27
EP1172100A1 (de) 2002-01-16
ITMI20001603A0 (it) 2000-07-14
ITMI20001603A1 (it) 2002-01-14
DE60131703D1 (de) 2008-01-17
JP2002080398A (ja) 2002-03-19
DE60131703T2 (de) 2008-11-20
US7022345B2 (en) 2006-04-04
CA2352496A1 (en) 2002-01-14
US20020034541A1 (en) 2002-03-21
AU776099B2 (en) 2004-08-26
AU5432401A (en) 2002-01-17

Similar Documents

Publication Publication Date Title
DE60131703D1 (de) Orale feste pharmazeutische Zusammensetzungen zur pH-abhängig mehrphasigen Freisetzung
DE60142890D1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
DE60138872D1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE233752T1 (de) Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
ATE337311T1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
EE05378B1 (et) LahustuvaÁCTLA4ÁsulandmolekuliÁkasutamineÁravimkoostiseÁvalmistamiseks
ATE355271T1 (de) Pharmazeutische zusammensetzung
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ATE320807T1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
DE602006000102D1 (de) Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
DK1401405T3 (da) Orale, farmaceutiske sammensætninger med forbedret biotilgængelighed
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
DE60100015D1 (de) Benzolsulfonamidderivate und Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DE602004018622D1 (de) Pharmazeutische zusammensetzung enthaltend 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylessigsäure
DE60200089D1 (de) Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE60200041D1 (de) Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen
DE60126046D1 (de) Bizyklische Amino-Pyrazon Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
DE60200023D1 (de) Isoindoloindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltende pharmazeutische Zusammensetzungen
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties